Yep, those higher assumed death rates in critical SOC patients would mean we don't need a huge trial.

The problem is controls. We need about 130 more people if we stick with a 2:1 randomization. Eyeballing it, a 1:1 randomization needs vicinity 90 more.

Again, this math is meaningless at the lower death solution.